Mycobacterium abscessus (Mabc) is an emerging human pathogen. Less is known about the host immune response to Mabc than to M. tuberculosis. Here, we examined the intracellular signaling pathways that govern the expression of chemokines including (C-C motif) ligand 2 (CCL2) and (C-X-C motif) ligand 2 (CXCL2) in macrophages after infection with Mabc. Specifically, Mabc triggered the generation of reactive oxygen species (ROS) and the production of CCL2 and CXCL2 in murine bone marrow-derived macrophages (BMDMs). Mabc-induced CCL2, but not CXCL2, was dependent on the generation of ROS. Toll-like receptor (TLR) 2, MyD88, but not TRIF, was required for Mabc-induced CCL2 and CXCL2 expression. Additionally, Mabc infection significantly induced nuclear factor (NF)-κB nuclear translocation and luciferase activity. The activation of NF-κB was required for Mabc-induced CCL2, but not CXCL2 expression. Moreover, Mabc-induced ROS generation was required for NF-κB activation. Treatment of BMDMs with Mabc rapidly induced the activation of mitogen-activated protein kinase (MAPKs) pathways. Interestingly, CCL2 expression was dependent on the activation of JNK and ERK1/2 pathways, whereas it was negatively regulated by the p38 MAPK pathway. In contrast, Mabc-dependent CXCL2 expression was not regulated by MAPK pathways. These data suggest that intracellular ROS generation is required for innate and inflammatory responses during Mabc infection of macrophages.
INTRODUCTION
Mycobacterium abscessus (Mabc), a rapidly growing mycobacterial species, is an emerging human pathogen that causes a variety of clinical syndromes. In immunocompromised hosts, Mabc can result in localized cutaneous lesions to disseminated infection (1) . Treatment of Mabc infection is problematic due to chemotherapy resistance and the requirement for long-term treatment (2) In TLR-dependent innate immune responses, two major intracellular signaling pathways, nuclear factor (NF)-κB and mitogen-activated protein kinases (MAPKs), play important roles in the activation of proinflammatory cytokine/chemokine production and antimicrobial protein generation, respectively. Recognition of microbial or danger patterns by TLRs trigger an intracellular signaling cascade that results in the activation of NF-κB, which leads to the expression of inflammatory cytokines and mediators (7, 9) .
MAPKs, a family of serine/threonine protein kinases, can be activated in response to external stress including mycobacteria (8) . Bacterial pathogens target and manipulate kinase pathways for their benefit (18, 19) . The activation of MAPK signaling pathways can lead to the synthesis of inflammatory cytokine production, making them therapeutic targets for a variety of inflammatory and infectious diseases (8, 17) .
In this study, we examined the roles of intracellular signaling pathways including ROS, TLR2, MyD88, TRIF, NF-κB, and MAPKs in the activation of chemokine generation by bone marrow-derived macrophages (BMDMs) after Mabc infection. We found that the expression of TLR2 and MyD88 are required for Mabc-induced expression of chemokines including chemokine (C-C motif) ligand 2 (CCL2) and (C-X-C motif) ligand 2 (CXCL2) by BMDMs.
Additionally, we found that Mabc-induced ROS and NF-κB activation contributes to the induction of CCL2, but not CXCL2, expression in BMDMs. Further, Mabc-induced CCL2 expression was regulated by the extracellular signalregulated protein kinases (ERK) 1/2 and c-Jun N-terminal kinase (JNK) pathways, whereas it was negatively regulated by the p38 MAPK pathway. However, Mabc-dependent CXCL2 expression was not regulated by either of the three MAPK subfamilies.
MATERIALS AND METHODS

Bacterial culture
Mabc (ATCC 19977) were grown as previously described 
Western blot analysis and Enzyme-Linked Immunosorbent assay (ELISA)
For Western blot analysis, cell lysate was boiled in sample buffer and separated by 12% SDS-PAGE gels. Proteins were transferred to polyvinyldifluoride membranes (PVDF; Millipore, Boston, MA, USA). Abs against p-SAPK/JNK, p-ERK1/2, p-p38, p-IKKα/β, and IκBα were diluted at a ratio of 1:1,000. Membranes were developed by ECL solution (Millipore; Danvers, MA, USA) and exposed to chemiluminescence film (Fujifilm, Japan). ELISA analysis was performed as described previously (16) . The cytokine levels measured were mouse CCL2 (BD PharMingen) and mouse CXCL2 (R&D Systems).
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) analysis
For semi-quantitative RT-PCR analysis, total RNA was extracted from cells using TRIzol (Invitrogen; Carlsbad, CA, USA), as described previously (16) . Primer sequences were as follows: mCcl2 (forward: 5'-ACTCAAGCCAGCTCT-
Annealing was performed at 56℃ for 45 s. RT-PCR products were visualized on 1.5% agarose gels and stained with ethidium bromide. Densitometry values were normalized to β-actin mRNA levels.
Measurement of intracellular ROS
Intracellular superoxide levels were measured as described previously (16) 
NF-κB luciferase reporter assay
NF-κB luciferase reporter assays were performed as described previously (20) . BMDMs were transduced with a NF-κB-Luc reporter plasmid (Genetransfer Vector Core; Iowa City, IA, USA) for 36 h, and infected with Mabc for 6 h. Infected cells were harvested and washed three times in PBS, and then lysed in luciferase lysis buffer (Promega;
Madison, WI, USA). A luciferase assay system (Promega) was used according to the manufacturer's instructions.
Results were normalized to protein content of three independent extracts.
Statistical Analysis
For statistical analysis, the data obtained from in- dependent experiments are presented as the means ± SD using Student's t-test. Statistical differences were considered significant if p < 0.05.
RESULTS
Mabc activate intracellular ROS and the production of CCL2 and CXCL2 in BMDMs
Previous studies reported that Mabc activate the production of proinflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), in BMDMs (16). We first examined whether Mabc infection of BMDMs induced the generation of ROS and production of CCL2 and CXCL2. Treatment of BMDMs with Mabc (moi = 3) significantly induced generation of ROS, which peaked at 30 min after infection (Fig. 1A) . Mabc-induced superoxide generation was rapidly and completely blocked by pre-treatment with the NADPH oxidase inhibitor DPI (Fig. 1A) , suggesting that Mabc-induced superoxide production is mediated through NADPH oxidase-dependent ROS.
We further examined the time-dependent mRNA and protein expression of CCL2 and CXCL2 in BMDMs after infection with Mabc. As shown in CCL2 and CXCL2 mRNA and protein.
Intracellular ROS generation is required for Mabcinduced CCL2, but not CXCL2 in BMDMs
We next investigated the roles of intracellular ROS in the expression of CCL2 and CXCL2 in BMDMs. To examine this, we pre-treated BMDMs with antioxidants NAC, DPI, and Tiron before Mabc infection. mRNA and proteins were collected from cell lysates and supernatants after 6 and 18 h of infection, respectively. As shown in Fig.   2A and B, pre-treatment of ROS scavengers significantly abolished Mabc-induced CCL2 mRNA and protein production in a dose-dependent manner. However, Mabcinduced CXCL2 mRNA and protein expression was not inhibited by pre-treatment of cells with ROS blockers ( Fig.   2A and B) . Together, these data suggest that Mabc-induced CCL2, but not CXCL2, production is dependent on intracellular ROS generation.
Both TLR2 and MyD88 are required for Mabcinduced CCL2 and CXCL2 in BMDMs
We previously reported that TLR2 is required for Mabcinduced TNF-α and IL-6 expression in BMDMs (16).
However, whether Mabc-induced CCL2 and CXCL2 production is mediated through TLR2 has not been investigated.
Moreover, the roles of MyD88 and TRIF in chemokine production during Mabc infection are unknown. Thus, we performed ELISA analysis of supernatants collected from Mabc-infected BMDMs from wild-type, TLR2 KO, MyD88 KO, and TRIF KO mice. Consistent with our previous study (16) , Mabc-induced CCL2 and CXCL2 protein synthesis was largely suppressed in TLR2-deficient BMDMs (Fig. 3A) . However, after Mabc treatment, basal levels of CCL2 and CXCL2 remained in TLR2-deficient BMDMs for 18 h (Fig. 3A) . We then examined the levels of Mabc-induced chemokine production in MyD88-or TRIF-deficient BMDMs. Notably, Mabcinduced CCL2 and CXCL2 production was nearly completely abrogated in MyD88-, but not TRIF-deficient, BMDMs (Fig. 3B) . We found that LPS-induced TNF-α and chemokine production was not decreased in TLR2-deficient BMDMs, whereas it was partially reduced in MyD88-and TRIF-deficient BMDMs (Fig. 3B and data not shown). Additionally, Pam3CSK4-dependent TNF-α A B Figure 3 . TLR2 and MyD88, but not TRIF, are essential for Mabc-induced chemokine production in BMDMs. BMDMs from (A) TLR2 WT and TLR2 KO or (B) WT, MyD88 KO, and TRIF KO mice were infected with Mabc (moi = 3) for 18 h. The supernatants were harvested and subjected to ELISA analysis of CCL2 and CXCL2 production. The results are the means ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 compared with each stimulator (Mabc, LPS, Pam3CSK4). U, uninfected; L, LPS; P, Pam3CSK4. and chemokine production was completely attenuated in TLR2-and MyD88-deficient BMDMs (Fig. 3B and data not shown). Together, Mabc-induced CXCL2 and CCL2 production was dependent on the expression of TLR2 and MyD88, but not TRIF, in BMDMs.
Mabc infection rapidly induces NF-κB activation, phosphorylation of IKKα/β, and degradation of IκBα in BMDMs
Because NF-κB activation is involved in TLR downstream signaling pathways (9), we hypothesized that Mabc infection drives the activation of NF-κB promoter activities.
To examine a possible role for Mabc in NF-κB activation, we performed a NF-κB luciferase assay in BMDMs transduced with adenovirus encoding a luciferase reporter plasmid containing response elements for NF-κB (Ad-NF-κB-Luc). As shown in Fig. 4A , Mabc stimulation significantly increased NF-κB reporter gene activities in BMDMs transduced with Ad-NF-κB-Luc, in a moi-dependent manner.
There was no significant increase in NF-κB promoter activities in cells transduced with control adenovirus (data not shown).
We also determined that the NF-κB p65 subunit translocated to the nucleus after Mabc infection. In BMDMs infected with Mabc, the nuclear translocation of NF-κB p65 is rapid, reaching maximal nuclear localization by 30 min (Fig. 4B, bottom) . The time-dependent appearance of NF-κB p65 in the nucleus was visualized by immunofluorescence 
NF-κB contributes to the expression of CCL2, but not CXCL2, in BMDMs through a ROS-dependent signaling pathway
Next we examined involvement of the NF-κB pathway in the production of CCL2 and CXCL2 in BMDMs treated with Mabc. Fig. 5A showed that the induction of mRNA expression of Ccl2, but not Cxcl2, in response to Mabc was abrogated in a dose-dependent fashion when BMDMs were pretreated with Bay11-7082 or CAPE, specific inhibitors of the NF-κB signalling pathway (22) . Accordingly, Mabcinduced CCL2, but not CXCL2, was impaired by a NF-κB inhibitor (Fig. 5B) .
We also investigated an interaction between NF-κB and ROS signaling pathways. When BMDMs were transduced with Ad-NF-κB-Luc, followed by pre-treatment with an antioxidant and Mabc stimulation, Mabc-induced NF-κB luciferase activities were significantly decreased in a dosedependent fashion by pre-treatment with ROS blockers (Fig.   5C ). These results indicate that ROS-dependent NF-κB signaling is essential for Mabc-induced CCL2, but not CXCL2, in BMDMs. We next determined the role of MAPKs in the induction of CCL2 and CXCL2. Pre-treatment of BMDMs with an inhibitor of p38 MAPK (SB203580) showed increased CCL2 production upon stimulation with Mabc (Fig. 6B) .
However, Mabc-induced CCL2 production was inhibited by a selective JNK inhibitor (SP600125) and an ERK1/2 inhibitor (U0126) (Fig. 6B) . In contrast, inhibitors of all 3 MAPK subfamilies had no effect on Mabc-induced CXCL2 secretion in BMDMs. Together, these data suggest that Mabc-induced CCL2, but not CXCL2, production is mediated through a JNK-and ERK1/2-dependent pathway.
Additionally, Mabc-induced CCL2 was negatively regulated by p38 MAPK in BMDMs. tuberculosis and atypical mycobacteria, and that they are involved in the generation of proinflammatory cytokines (15, 16) . It was also reported that Mabc and M. avium induce TNF-α production, which is dependent on the p38 MAPK pathway (37) . Recent studies showed that M. tuberculosis inhibits interferon-γ-induced protein 10 (IP-10) and macrophage-induced gene (MIG), both of which are associated with host defense against mycobacteria and are regulated by the p38 MAPK-dependent pathway (38) .
However, current data show that CXCL2 and CCL2 are distinctly regulated by three families of MAPKs: Mabcinduced CCL2 secretion is dependent on JNK and ERK1/2, but not the p38 MAPK pathway; Mabc-induced CXCL2 is independent on three families of MAPKs. These data suggest that TLR2-dependent NF-κB and MAPK pathways are required for the expression of Mabc-induced CCL2, but not CXCL2, in macrophages.
